行情

PRGO

PRGO

培瑞克
NYSE

实时行情|Nasdaq Last Sale

52.29
+0.48
+0.93%
盘后: 52.29 0 0.00% 17:52 12/06 EST
开盘
52.10
昨收
51.81
最高
52.67
最低
51.86
成交量
95.60万
成交额
--
52周最高
63.60
52周最低
36.28
市值
71.17亿
市盈率(TTM)
28.94
分时
5日
1月
3月
1年
5年

分析师评级

13位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

PRGO 新闻

  • Perrigo (PRGO) Up 4.1% Since Last Earnings Report: Can It Continue?
  • Zacks.7小时前
  • UPDATE 2-Mexico's Televisa wins injunction on part of Disney-Fox deal; merger unaffected
  • Reuters.21小时前
  • Perrigo (PRGO) Presents At Morgan Stanley Global Consumer and Retail Conference - Slideshow
  • Seeking Alpha - Article.1天前
  • Edited Transcript of PRGO earnings conference call or presentation 6-Nov-19 1:00pm GMT
  • Thomson Reuters StreetEvents.1天前

更多

所属板块

制药
+0.11%
制药与医学研究
+0.32%

热门股票

名称
价格
涨跌幅

PRGO 简况

Perrigo Company PLC (Perrigo), formerly Perrigo Company Limited, is an over-the-counter (OTC) consumer goods and specialty pharmaceutical company. The Company's segments include Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx) and Specialty Sciences. It manufactures OTC healthcare products and supplies infant formulas for the store brand market. It is also a provider of generic extended topical prescription products. The CHC segment is focused on the sale of OTC store brand products. The BCH segment develops, manufactures, markets and distributes various European OTC brands. The Rx segment develops, manufactures and markets a portfolio of generic and specialty pharmaceutical prescription drugs. The Specialty Sciences segment consists of assets focused on the treatment of multiple sclerosis, specifically in connection with the drug, Tysabri.
展开

Webull提供Perrigo Company PLC的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。